These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 62316)

  • 1. [Adjuvant immunotherapy with BCG for malignant brain tumors (author's transl)].
    Miki Y; Sano K; Takakura K; Mizutani H
    Neurol Med Chir (Tokyo); 1976 Jul; 16(4 pt 2):357-64. PubMed ID: 62316
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
    Azuma I; Yamamura Y
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunology of brain tumors (author's transl)].
    Takakura K
    No To Shinkei; 1976 Jun; 28(6):525-37. PubMed ID: 194610
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunochemistry of tubercle bacilli, with special reference to adjuvant activity (author's transl)].
    Azuma I
    Kekkaku; 1981 Dec; 56(12):595-607. PubMed ID: 7035731
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vaccines against infectious rhinotracheitis of the cat adjuvant BCG aluminium hydroxide (preparation, control, immunity (author's transl)].
    Metianu T
    Comp Immunol Microbiol Infect Dis; 1979; 2(4):497-504. PubMed ID: 398244
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients.
    Grooms GA; Eilber FR; Morton DL
    J Surg Oncol; 1977; 9(2):147-53. PubMed ID: 325299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
    Yamamura Y; Yoshizaki K; Azuma I; Yagura T; Watanabe T
    Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cancer immunotherapy and its fundamental basis (author's transl)].
    Yamamura Y
    Nihon Hifuka Gakkai Zasshi; 1976 Sep; 86(10):584-91. PubMed ID: 796500
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G; Halle-Pannenko O; Bourut C
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor activity of hot-water extract from delipidated BCG.
    Sato H; Yokosawa A; Arai H; Nagai H; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1978 Jul; 125(3):247-52. PubMed ID: 358496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated macrophages and the antitumor action of BCG.
    Alexander P
    Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
    [No Abstract]   [Full Text] [Related]  

  • 14. The second generation of EORTC-ECIG experimental screening for systemic immunity adjuvants. Its significance for cancer immunotherapy. A comparison of BCG and its hydrosoluble extract.
    Mathe G; Halle-Pannenko O; Florentin I; Bruley-Rosset M; Kamel M; Hiu IJ; Bourut C
    Eur J Cancer (1965); 1975 Nov; 11(11):801-7. PubMed ID: 767112
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gram-positive bacteria as adjuvants (author's transl)].
    Hahn H
    Immun Infekt; 1978 Jun; 6(3):123-6. PubMed ID: 96006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological adjuvants in cancer immunotherapy.
    Baldwin RW
    Dev Biol Stand; 1977 Apr 13-15; 38():3-12. PubMed ID: 344097
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunotherapy of cancer with BCG].
    Yamamura Y; Azuma I
    Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
    [No Abstract]   [Full Text] [Related]  

  • 18. [The influence of Mycobacterium bovis BCG-prague, respectively of Mycobacterium smegmatis on the growth of the intratracheally transplanted Deal's sarcoma in guinea pigs (author's transl)].
    Schwartz E; Vincúrová M; Badalik L
    Bratisl Lek Listy; 1975 Sep; 64(3):272-84. PubMed ID: 1098744
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
    Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
    [No Abstract]   [Full Text] [Related]  

  • 20. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.